Loading...
LENSAR, Inc.
LNSR•NASDAQ
Healthcare
Medical - Devices
$13.05
$0.12(0.93%)
LENSAR, Inc. (LNSR) Financial Performance & Income Statement Overview
Review LENSAR, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
26.87%
↑ 26.87%
Operating Income Growth
51.21%
↑ 51.21%
Net Income Growth
-118.34%
↓ 118.34%
Operating Cash Flow Growth
76.45%
↑ 76.45%
Operating Margin
-16.49%
↓ 16.49%
Gross Margin
47.45%
↑ 47.45%
Net Profit Margin
-99.17%
↓ 99.17%
ROE
-527.81%
↓ 527.81%
ROIC
-20.56%
↓ 20.56%
LENSAR, Inc. (LNSR) Income Statement & Financial Overview
Review LENSAR, Inc.'s (LNSR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $16.73M | $13.54M | $12.64M | $10.59M |
| Cost of Revenue | $9.62M | $7.27M | $6.05M | $5.20M |
| Gross Profit | $7.11M | $6.27M | $6.58M | $5.39M |
| Gross Profit Ratio | $0.42 | $0.46 | $0.52 | $0.51 |
| R&D Expenses | $1.33M | $1.20M | $1.35M | $1.44M |
| SG&A Expenses | $6.83M | $6.08M | $6.78M | $6.80M |
| Operating Expenses | $8.40M | $7.28M | $8.13M | $8.24M |
| Total Costs & Expenses | $17.28M | $14.55M | $14.19M | $13.44M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.11M | $1.006M | $898000.00 | $921000.00 |
| EBITDA | -$184000.00 | -$239000.00 | -$653000.00 | -$1.93M |
| EBITDA Ratio | -$0.01 | -$0.02 | -$0.05 | -$0.18 |
| Operating Income | -$1.29M | -$1.01M | -$1.55M | -$2.85M |
| Operating Income Ratio | -$0.08 | -$0.07 | -$0.12 | -$0.27 |
| Other Income/Expenses (Net) | -$17.41M | -$489000.00 | -$7.49M | $693000.00 |
| Income Before Tax | -$18.70M | -$1.50M | -$9.04M | -$2.16M |
| Income Before Tax Ratio | -$1.12 | -$0.11 | -$0.72 | -$0.20 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $877724.00 |
| Net Income | -$18.70M | -$1.50M | -$9.04M | -$2.16M |
| Net Income Ratio | -$1.12 | -$0.11 | -$0.72 | -$0.20 |
| EPS | -$1.61 | -$0.13 | -$0.79 | -$0.19 |
| Diluted EPS | -$1.61 | -$0.13 | -$0.79 | -$0.19 |
| Weighted Avg Shares Outstanding | $11.63M | $11.60M | $11.45M | $11.39M |
| Weighted Avg Shares Outstanding (Diluted) | $11.63M | $11.60M | $11.45M | $11.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan